Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder

NCT01302938 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class

Stopped Stop date for randomization: 31/5/2012. Recruitment terminated due to lack of recruitment. No new safety issues were identified.

Conditions

Interventions

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.